GFM
MRNA icon

GF Fund Management’s Moderna MRNA Stock Holding History

GF Fund Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$549K Sell
7,839
-936
-11% -$48.4K 0.01% 209
2026
Q1 		$446K Buy
8,775
+1,098
+14% +$51.2K 0.01% 226
2025
Q4 		$226K Sell
7,677
-694
-8% -$18.9K ﹤0.01% 284
2025
Q3 		$216K Sell
8,371
-1,482
-15% -$41.3K ﹤0.01% 283
2025
Q2 		$272K Sell
9,853
-533
-5% -$14K 0.01% 295
2025
Q1 		$294K Buy
10,386
+1,435
+16% +$50.9K 0.01% 290
2024
Q4 		$372K Buy
+8,951
New +$428K 0.01% 245

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

GF Fund Management's MRNA Position: Q2 2026 in Review

GF Fund Management reduced its Moderna (MRNA) stake by 11% in Q2 2026, selling an estimated $48.4K and leaving 7,839 shares worth $549K. The position accounts for 0.01% of the portfolio, ranked #209.

GF Fund Management first reported a position in MRNA in Q4 2024 and has held it in 7 quarters since. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • GF Fund Management held 7,839 shares of Moderna worth $549K as of Q2 2026.
  • GF Fund Management sold 936 Moderna shares in Q2 2026, an estimated $48.4K.
  • Moderna made up 0.01% of GF Fund Management's portfolio in Q2 2026, its #209 holding.
  • GF Fund Management first reported a position in Moderna in Q4 2024 and has held it in 7 quarters since.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.